Streetbeat News

TCNNF

Trulieve Cannabis Corp

Employees

9,000

Industry

Medicinal and Botanical Manufacturing

Open

7.21

Mkt cap

1.5B

Volume

276K

High

7.85

P/E Ratio

-10.92

52-wk high

14.50

Low

7.21

Div yield

N/A

52-wk low

4.75

Senior analyst Pablo Zuanic from Zuanic & Associates has provided a valuation assessment of US Multi-State Operators (MSOs) in the cannabis sector, considering potential federal regulatory changes and state-level legalization trends. He uses a comprehensive methodology to calculate enterprise values (EV) for MSOs, including Acreage Holdings, Ascend Wellness, Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, and Verano. The analysis is based on factors such as share counts, net debt, and contingent liabilities. The US legal cannabis market is expected to grow significantly, from $18 million in CY20 to $40 million in CY27, indicating a positive outlook for MSOs.

Portfolio Pulse from Nicolás Jose Rodriguez

November 17, 2023 | 4:01 pm

Marijuana stocks experienced significant volatility with some companies seeing extreme gains while others faced steep losses. Notable gainers included MPX International and GrowLife, with MPX International closing up 7000.00% and GrowLife closing down 33.00%. The article lists numerous other cannabis-related companies with varying degrees of price changes on the trading day.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 9:30 pm

Cannabis stocks experienced significant movements on November 13, 2023. Notable gainers included AusCann Group Holdings, Auxly Cannabis Group, and Rocky Mountain High, with increases of 66.67%, 46.94%, and 26.32% respectively. Eastside Distilling, Cara Therapeutics, and SNDL also saw substantial gains. Conversely, EVIO led the losers with a 98% decline, followed by Global Hemp Group and 1933 Industries. Other notable decliners included Heritage Cannabis Holding, Elixinol Wellness, and Corbus Pharmaceuticals.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:30 pm

The recent earnings reports from eight major Multi-State Operators (MSOs) in the cannabis industry show mixed results on revenue and EBITDA, but the standout detail is the positive Cash Flow from Operations (CFFO) in Q3. Most companies beat consensus projections for CFFO, with tax deferrals being a significant driver. Investors are advised to focus on CFFO rather than revenue or EBITDA, and to distinguish between repeatable cash flows and future cash outflows due to deferred payments. The Viridian Cannabis Deal Tracker provides insights into capital raise and M&A activity in the cannabis sector.

Portfolio Pulse from Viridian Capital Advisors

November 13, 2023 | 4:47 pm

The article reports significant movements in marijuana stocks on November 10, 2023. Notable gainers include GrowLife, Affinor Growers, and Belgravia Hartford Cap with increases of 400%, 146.39%, and 134.38% respectively. Corbus Pharmaceuticals and Psychemedics also saw substantial gains. On the losing side, Green Growth Brands experienced a significant drop of 90%. The movements reflect the volatile nature of the marijuana industry and could be influenced by regulatory news, earnings reports, or market sentiment.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 9:30 pm

Needham analyst Matt McGinley has maintained a 'Buy' rating on Trulieve Cannabis (OTC:TCNNF) but lowered the price target from $9 to $6.5.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:58 pm

Trulieve Cannabis Corp. reported Q3 financial results, with revenue of $275.2 million, down from $295.4 million YoY and $282 million in the previous quarter. The company's net loss was $25 million, significantly lower than the $115.1 million loss a year ago, largely due to a 39% YoY reduction in operating expenses. The company expects 2023 operating cash flow of at least $100 million and free cash flow of at least $70 million.

Portfolio Pulse from Nina Zdinjak

November 09, 2023 | 1:56 pm

Trulieve Cannabis (OTC:TCNNF) reported its Q3 earnings, beating estimated earnings by 52.94% with an EPS of $-0.08 versus an estimate of $-0.17. However, revenue was down $25.59 million from the same period last year. Last quarter, the company also beat EPS estimates, which was followed by a 1.43% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 11:20 am

The article lists the cannabis stocks that gained and lost on November 8, 2023. Notable gainers include EVIO, Psychemedics, 4Front Ventures, and Corbus Pharmaceuticals. On the other hand, significant losers include Item 9 Labs, CNBX Pharmaceuticals, Kaya Holdings, and Auxly Cannabis Group.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:30 pm

Florida's Supreme Court is reviewing a citizen-led initiative by Smart & Safe Florida, backed by Trulieve Cannabis Corp (OTCQX:TCNNF), to legalize adult-use cannabis. The initiative has nearly one million signatures and promises economic growth, but faces questions about federal legality. The initiative seeks to allow adults aged 21 and older to purchase and possess up to three ounces of cannabis for personal use. Meanwhile, Florida's Sanctuary Cannabis has filed a lawsuit against the state, challenging the increase in the biennial medical marijuana licensing fee.

Portfolio Pulse from Nicolás Jose Rodriguez

November 08, 2023 | 8:55 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.